
|Articles|January 25, 2008
Bausch & Lomb to buy eyeonics
Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.
Advertisement
Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.
Upon completion of the deal, Bausch & Lomb will absorb eyeonics' operations as part of its surgical business. Eyeonics generated approximately $34 million in revenue in 2007, a 100% increase over the prior year.
The acquisition is expected to complete within the first quarter of 2008.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD
3
Think outside the cone: Applying the Gulani Keratoconus Classification
4
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
5


















